Download PDF
Thromb Haemost 1960; 4(03): 389-399
DOI: 10.1055/s-0038-1654522
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

The Effect of Heparin on the Bleeding Time

P. F Hjort
1   Universitetets Institutt for Tromboseforskning, Rikshospitalet, Oslo. Universitetets Institutt for Generell og Eksperimentell Patologi, Rikshospitalet, Oslo. Fysiologisk Institutt, Veterinærhöyskolen, Oslo, Norway
,
C. F Borchgrevink
1   Universitetets Institutt for Tromboseforskning, Rikshospitalet, Oslo. Universitetets Institutt for Generell og Eksperimentell Patologi, Rikshospitalet, Oslo. Fysiologisk Institutt, Veterinærhöyskolen, Oslo, Norway
,
O. H Iversen
1   Universitetets Institutt for Tromboseforskning, Rikshospitalet, Oslo. Universitetets Institutt for Generell og Eksperimentell Patologi, Rikshospitalet, Oslo. Fysiologisk Institutt, Veterinærhöyskolen, Oslo, Norway
,
H Stormorken
1   Universitetets Institutt for Tromboseforskning, Rikshospitalet, Oslo. Universitetets Institutt for Generell og Eksperimentell Patologi, Rikshospitalet, Oslo. Fysiologisk Institutt, Veterinærhöyskolen, Oslo, Norway
› Author Affiliations
Further Information

Publication History

Publication Date:
17 June 2018 (online)

Also available at
    Permissions and Reprints

Summary and Conclusions

1. Moderate doses of heparin often prolonged the bleeding time in men, rats and mice. The bleeding was wavelike, and a sensitive method was necessary to demonstrate the prolongation.

2. Large doses gave a prolonged bleeding time, and the bleeding was often profuse and continuous.

3. Heparin did not produce thrombocytopenia. Moderate doses probably prevent viscous metamorphosis and fibrin formation, resulting in large but inefficient platelet plugs. Large doses may also interfere with the aggregation of platelets, preventing the formation of platelet plugs.

 

  • References

  • (1) Apitz K. Die Bedeutung der Gerinnung und Thrombose für die Blutstillung. Virchows Arch. path. Anat. 308: 540-614 1942;
    CrossrefPubMedSearch in Google Scholar
  • (2) Best C. H, Campbell C, Maclean D. L. Heparin and the formation of white thrombi. J. Physiol. (Lond.) 92: 20-31 1938;
    CrossrefPubMedSearch in Google Scholar
  • (3) Bergsagel D. E. Viscous metamorphosis of platelets: morphological platelet changes induced by an intermediate product of blood thromboplastin formation. Brit. J. Haemat. 2: 130-138 1956;
    CrossrefPubMedSearch in Google Scholar
  • (4) Berman H. J, Fullon G. P, Lutz B. R, Pierce D. L. Susceptibility to thrombosis in normal young, aging, cortisone-treated, heparinized and X-irradiated hamsters as tested by topical application of thrombin. Blood 10: 831-840 1955;
    PubMedSearch in Google Scholar
  • (5) Borchgrevink C. F, Waaler B. A. The secondary bleeding time. Acta med. scand. 162: 361-374 1958;
    PubMedSearch in Google Scholar
  • (6) Bounameaux Y. Action de la thrombine et de la reptilase sur la métamorphose visqueuse des plaquettes de diverses espèces animales. Rev. franç. Ét. clin. biol. 4: 54-55 1959;
    PubMedSearch in Google Scholar
  • (7) Brecher G, Cronkite E. P. Morphology and enumeration of human blood platelets. J. appl. Physiol. 3: 365-377 1950;
    CrossrefPubMedSearch in Google Scholar
  • (8) Cauwenberge H. van, Jaques L. B. Effect of dicumarol on bleeding time. Proc. Soc. exp. Biol. (N. Y.) 98: 599-602 1958;
    CrossrefPubMedSearch in Google Scholar
  • (9) Copley A. L, Lalich J. J. The experimental production of a hemophilia-like condition in heparinized mice. Amer. J. Physiol. 135: 547-556 1942; a
    PubMedSearch in Google Scholar
  • (10) Copley A. L, Lalich J. J. Bleeding time, lymph time, and clot resistance in man. J. clin. Invest. 21: 145-152 1942; a
    CrossrefPubMedSearch in Google Scholar
  • (11) Copley A. L, Robb T. P. Studies on platelets. III. The effect of heparin in vivo on the platelet count in mice and dogs. Amer. J. clin. Path. 12: 563-570 1942;
    PubMedSearch in Google Scholar
  • (12) Correll J. T, Lyth L. F, Long S, Vanderpoel J. C. Some physiologic responses to 5-hydroxytryptamine creatinine sulfate. Amer. J. Physiol. 169: 537-544 1952;
    PubMedSearch in Google Scholar
  • (13) Fullon G. P, Akers R. P, Lutz B. R. White thromboembolism and vascular fragility in the hamster cheek pouch after anticoagulants. Blood 8: 140-152 1953;
    PubMedSearch in Google Scholar
  • (14) Ganes J. Nord. Med. 16: 2841 1942;
    PubMedSearch in Google Scholar
  • (15) Halse T. Methodischer Beitrag zur experimentellen Prüfung der Blutungszeit. Klin. Wschr. 30: 693-694 1952;
    CrossrefPubMedSearch in Google Scholar
  • (16) Hedenius P. Further experiences with heparinizing the donor in blood transfusions. Lancet 2: 1186-1188 1937;
    PubMedSearch in Google Scholar
  • (17) Heim W. Die indirekte Bluttransfusion mit „Vetren“. Münch. med. wschr. 85: 1157-1160 1938;
    PubMedSearch in Google Scholar
  • (18) Hjort P, Stormorken H. A study of the in vitro and in vivo effects of a synthetic heparin-like anticoagulant: dextran sulphate. Scand. J. clin. Lab. Invest. 9 (Suppl. 29) 1-86 1957;
    CrossrefPubMedSearch in Google Scholar
  • (19) Hugues J. Contribution a l’étude des facteurs vasculaires et sanguines dans l'hémostase spontanée. Thesis. Liège: 1953: 1-151.
    Search in Google Scholar
  • (20) Hugues J. Metamorphose visqueuse des plaquettes et formation du clou hémostatique. Thromb. Diath. haem. 3: 34-44 1959;
    PubMedSearch in Google Scholar
  • (21) Jores A, Detzel A. Heparin und seine praktische Anwendung. Klin. Wschr 19: 641-647 1940;
    CrossrefPubMedSearch in Google Scholar
  • (22) Lalich J. J, Copley A. L. Clot resistance in mice and the mechanism of hemostasis. Arch. Surg. 46: 224-237 1943;
    CrossrefPubMedSearch in Google Scholar
  • (23) Lalich J. J, Lalich M. H, Copley A. L. Bleeding time in mice following the administration of 3,3’-methylene-bis-(4-hydroxycoumarin). Surgery 13: 316-321 1943;
    PubMedSearch in Google Scholar
  • (24) Lewalle J, Bounameaux Y, Roskam J. Étude clinique “in vivo“ de la résistance du clou hémostatique chez l’homme. Thromb. Diath. haem. 3: 165-176 1959;
    PubMedSearch in Google Scholar
  • (25) Lindgren S, Wilander O. The use of heparin in vascular surgery. Acta med. scand 107: 148-160 1941;
    PubMedSearch in Google Scholar
  • (26) Macfarlane R. G. The mechanism of hemostasis. Quart. J. Med. 10: 129 1941;
    PubMedSearch in Google Scholar
  • (27) Quick A. J, Shanberge J. N, Stefanini M. The effect of heparin on platelets in vivo. J. Lab. clin. Med. 33: 1424-1430 1948;
    PubMedSearch in Google Scholar
  • (28) Roskam J. Mécanisme de la prévention et du traitement des thromboses par l’héparine. Arch. int. Pharmacodyn. 68: 66-80 1942;
    PubMedSearch in Google Scholar
  • (29) Sappington S. W. The use of heparin in blood transfusions. J. Amer. med Ass. 113: 22-25 1939;
    CrossrefPubMedSearch in Google Scholar
  • (30) Shionoya T. Studies in experimental extracorporeal thrombosis. III. Effects of certain anticoagulants (heparin and hirudin) on extracorporeal thrombosis and on the mechanism of thrombus formation. J. exp. Med. 46: 19-26 1927;
    CrossrefPubMedSearch in Google Scholar
  • (31) Sköld E. Heparin bei Blutttransfusionen. Acta med. scand. 88: 450-454 1936;
    PubMedSearch in Google Scholar
  • (32) Waaler B. A. Contact activation in the intrinsic blood clotting system. Scand. J. clin. Lab. Invest. 11 (Suppl. 37) 1-133 1959;
    CrossrefPubMedSearch in Google Scholar
  • (33) Zucker H. D. Platelet thrombosis in human hemostasis. Blood 4: 631-645 1949;
    PubMedSearch in Google Scholar
  • (34) Zucker M. B. Platelet agglutination and vasoconstriction as factors in spontaneous hemostasis in normal, thrombocytopenic, heparinized and hypoprothrombinemie rats. Amer. J. Physiol. 148: 275-288 1947;
    PubMedSearch in Google Scholar
  • (35) Zucker M. B, Borrelli J. Viscous metamorphosis, clot retraction and other morphologic alterations of blood platelets. J. appl. Physiol. 14: 575-580 1959;
    CrossrefPubMedSearch in Google Scholar